Healthcare
Live Price
Offline$0.014
+55.56% today
1Y Change
-52.57%
Window
Jun 23, 2025 → Jun 9, 2026
Coverage: 245 bars · Jun 23, 2025 → Jun 9, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Sibannac, Inc. (SNNC) is a Healthcare stock with listed on OTC. The stock last traded around $0.01 and down 52.6% across the available one-year price window (Jun 23, 2025 → Jun 9, 2026). Baseline metrics include revenue growth of +113.8%, EPS growth of +49.3%, a dividend yield of 0.0%. What stands out right now is revenue +113.8%, EPS +49.3%, free cash flow 0.0% with operating margin -3152.1% and ROIC 558.1%. Valuation already assumes a fairly strong business story at price/sales 71.0. Overall, the current profile looks closer to a higher-growth but lower-margin setup than a generic broad-market placeholder. Stock Foundry combines SNNC price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
SNNC
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
SNNC Max Drawdown
-81.66%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for SNNC and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$157.3K
+2352.2% YoY
FY Net Income
-$566.0K
+4.5% YoY
Free Cash Flow
-$1.9M
-693.5% YoY
Revenue Growth
+113.8%
EPS Growth
+49.3%
Gross Margin
2.7%
Net Margin
-3484.6%
Income statement
USD
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 6K | 3K | 434 | 6K | 157K |
| Gross Profit | 245 | 2K | 226 | 4K | 57K |
| Operating Income | -347K | -269K | -519K | -529K | -487K |
| EBITDA | -347K | -716K | 136K | 9K | 30K |
| Net Income | -391K | -755K | -421K | -593K | -566K |
| EPS (Diluted) | — | — | — | — | — |
Balance sheet
USD
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Cash & Equivalents | 8K | 500 | 7 | 14K | 41K |
| Total Assets | 801K | 738K | 1M | 882K | 922K |
| Total Liabilities | 2M | 1M | 1M | 650K | 2M |
| Shareholder Equity | -718K | -725K | 30K | 233K | -1M |
| Total Debt | 647K | 565K | 629K | 324K | 537K |
| Net Debt | 639K | 565K | 629K | 310K | 496K |
Cash flow positioning
Latest Full Year
Operating Cash Flow
2M
-385.8% YoY
Capital Expenditures
0
+100.0% YoY
Free Cash Flow
2M
-693.5% YoY
Key ratios
Gross Margin
2.7%
Operating Margin
-3152.1%
Net Margin
-3484.6%
ROE
49.0%
Debt / Equity
-0.74x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.